Tag Archives: patients

FDA Approves Fensolvi (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty

FDA Approves Fensolvi (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty Print this page BUFFALO GROVE, Ill., May 4, 2020 /PRNewswire/ — Tolmar Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application for Fensolvi (leuprolide acetate) for injectable suspension for the treatment… Read More »

Up to 10 percent of recovered coronavirus patients test positive again, report says

Get all the latest news on coronavirus and more delivered daily to your inbox.  Sign up here. As many as 10% of recovered coronavirus patients in China tested positive again after being discharged from the hospital, according to a report. Doctors on the front lines of the outbreak in Wuhan, China — where the virus emerged —… Read More »

FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients

FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients Print this page DUBLIN, March 5, 2020 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food and Drug Administration (FDA) has… Read More »

FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma

FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma Print this page BRIDGEWATER, N.J., March 2, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with pomalidomide and dexamethasone (pom-dex) for the treatment of adults with relapsed refractory multiple myeloma (RRMM) who have received at least… Read More »

US health officials will check patients with flu-like symptoms for coronavirus

National Center for Immunization and Respiratory Diseases Director Nancy Messonnier speaks during a press conference today at the Department of Health and Human Services on the coordinated public health response to the 2019 coronavirus (2019-nCoV), January 28, 2020 in Washington, DC. Samuel Corum U.S. health officials will monitor people with flu-like symptoms for the coronavirus… Read More »